NuCana Plc (NCNA)
1.47
-0.05
(-3.29%)
USD |
NASDAQ |
Aug 24, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
NuCana Total Liabilities (Quarterly) : 7.330M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.330M |
| March 31, 2026 | 6.839M |
| December 31, 2025 | 7.407M |
| September 30, 2025 | 8.601M |
| June 30, 2025 | 12.11M |
| March 31, 2025 | 9.586M |
| December 31, 2024 | 11.05M |
| September 30, 2024 | 20.37M |
| June 30, 2024 | 20.57M |
| March 31, 2024 | 18.53M |
| December 31, 2023 | 16.48M |
| September 30, 2023 | 14.88M |
| June 30, 2023 | 17.64M |
| March 31, 2023 | 21.02M |
| December 31, 2022 | 23.76M |
| September 30, 2022 | 17.82M |
| June 30, 2022 | 12.87M |
| Date | Value |
|---|---|
| March 31, 2022 | 16.73M |
| December 31, 2021 | 16.15M |
| September 30, 2021 | 16.64M |
| June 30, 2021 | 11.23M |
| March 31, 2021 | 12.98M |
| December 31, 2020 | 11.70M |
| September 30, 2020 | 12.42M |
| June 30, 2020 | 8.613M |
| March 31, 2020 | 8.137M |
| December 31, 2019 | 8.937M |
| September 30, 2019 | 7.068M |
| June 30, 2019 | 8.871M |
| March 31, 2019 | 7.266M |
| December 31, 2018 | 7.121M |
| September 30, 2018 | 6.820M |
| June 30, 2018 | 5.504M |
| March 31, 2018 | 3.538M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 6.062M |
| BioNTech SE | 2.956B |
| Silence Therapeutics Plc | 67.94M |
| Compass Pathways Plc | 420.03M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.22M |
| Shareholders Equity (Quarterly) | 26.89M |
| Debt to Equity Ratio | 0.0332 |
| Current Ratio | 4.729 |
| Net Debt Paydown Yield | -2.04% |